154 related articles for article (PubMed ID: 1283053)
1. [Prostatic specific antigen (PA) in mass screening for prostate cancer].
Ito K; Ohtake N; Hatori M; Mashimo T; Jimbo S; Tomaru Y; Makino T; Yajima H; Imai K; Yamanaka H
Hinyokika Kiyo; 1992 Nov; 38(11):1225-9. PubMed ID: 1283053
[TBL] [Abstract][Full Text] [Related]
2. Prostate-specific antigen in mass screening for carcinoma of the prostate.
Shimizu TS; Uchida T; Satoh J; Imai K; Yamanaka H
Int J Urol; 1995 Sep; 2(4):257-60. PubMed ID: 8564745
[TBL] [Abstract][Full Text] [Related]
3. [Significance of prostatic specific antigen in the mass screening for prostate cancer].
Imai K; Suzuki T; Kuribara J; Ito K; Ootake N; Hatori M; Yamanaka H; Tomaru Y; Jinbo S; Kiren H
Nihon Hinyokika Gakkai Zasshi; 1992 Sep; 83(9):1484-9. PubMed ID: 1279261
[TBL] [Abstract][Full Text] [Related]
4. [Prostatic acid phosphatase (PAP), gamma-seminoprotein (gamma-Sm) and prostate specific antigen (PA) in prostatic cancer].
Akimoto S; Akakura K; Shimazaki J
Hinyokika Kiyo; 1988 Aug; 34(8):1389-96. PubMed ID: 2461644
[TBL] [Abstract][Full Text] [Related]
5. [Measurement of serum PSA by DELFIA PSA kit and its application for mass screening. The Gunma Urological Oncology Study Group].
Imai K; Watanabe K; Higashi H; Shinya H; Okamura K; Matsuo Y; Yazima H; Takezawa Y; Yamanaka H
Hinyokika Kiyo; 1993 Sep; 39(9):807-12. PubMed ID: 7692709
[TBL] [Abstract][Full Text] [Related]
6. [Diagnostic accuracy of transrectal ultrasonography for screening of prostatic cancer].
Watanabe M; Saitoh M; Watanabe H
Hinyokika Kiyo; 1996 Oct; 42(10):763-6. PubMed ID: 8951472
[TBL] [Abstract][Full Text] [Related]
7. [Prostate specific antigen in serum of the patients with prostatic cancer].
Akimoto S; Akakura K; Fuse H; Shimazaki J
Hinyokika Kiyo; 1988 Apr; 34(4):636-42. PubMed ID: 2456678
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of prostate specific antigen for early stage prostate cancer detection.
Imai K; Ichinose Y; Kubota Y; Yamanaka H; Sato J; Saitoh M; Watanabe H; Ohe H
Jpn J Clin Oncol; 1994 Jun; 24(3):160-5. PubMed ID: 7516445
[TBL] [Abstract][Full Text] [Related]
9. [Clinical evaluation of a prostate-specific antigen as a serum marker of prostatic cancer].
Park YC; Kiwamoto H; Nishioka T; Tsujihashi H; Mitsubayashi S; Matsuura T; Akiyama T; Kurita T; Miyamoto T
Hinyokika Kiyo; 1987 Jun; 33(6):883-8. PubMed ID: 2445188
[TBL] [Abstract][Full Text] [Related]
10. [Tumor markers of prostate cancer--evaluation of serum PAP and PA].
Miki M
Gan No Rinsho; 1985 May; 31(6 Suppl):664-9. PubMed ID: 2411965
[TBL] [Abstract][Full Text] [Related]
11. [Detection of prostate cancer in urological practice: clinical establishment of serum PSA reference values by age].
Yamazaki H; Suzuki Y; Madarame A; Katoh N; Masuda F; Ohishi ; Endo K
Nihon Hinyokika Gakkai Zasshi; 1996 Mar; 87(3):702-9. PubMed ID: 8709448
[TBL] [Abstract][Full Text] [Related]
12. Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening.
Catalona WJ; Smith DS; Ratliff TL; Basler JW
JAMA; 1993 Aug; 270(8):948-54. PubMed ID: 7688438
[TBL] [Abstract][Full Text] [Related]
13. Conditions associated with normal levels of prostate-specific antigen and elevation of prostatic acid phosphatase.
Lloyd AJ; Formby MR
Am J Clin Oncol; 1992 Dec; 15(6):487-9. PubMed ID: 1280403
[TBL] [Abstract][Full Text] [Related]
14. Prostate adenocarcinoma using Gleason scores correlates with prostate-specific antigen and prostate acid phosphatase measurements.
Shih WJ; Gross K; Mitchell B; Collins J; Wierzbinski B; Magoun S; Ryo UY
J Natl Med Assoc; 1992 Dec; 84(12):1049-50. PubMed ID: 1284282
[TBL] [Abstract][Full Text] [Related]
15. Prostate-specific antigen in prostate cancer.
Kuriyama M
Int J Biol Markers; 1986; 1(2):67-76. PubMed ID: 2448397
[TBL] [Abstract][Full Text] [Related]
16. [Clinical studies on tumor markers for monitoring prostate cancer patients; the evaluation of prostate-specific antigen and comparison with prostatic acid phosphatase and gamma-seminoprotein].
Shinoda I
Nihon Gan Chiryo Gakkai Shi; 1990 Nov; 25(11):2627-39. PubMed ID: 1703555
[TBL] [Abstract][Full Text] [Related]
17. [Measurements of prostatic acid phosphatase and prostate specific antigen by fully automated enzyme immunoassay system--its analytical and clinical evaluation].
Matui A; Yamada T; Sugita O; Yakata M
Rinsho Byori; 1990 Jun; 38(6):693-8. PubMed ID: 1696328
[TBL] [Abstract][Full Text] [Related]
18. Multiple marker evaluation in prostatic cancer using prostatic specific antigen, gamma-seminoprotein and prostatic acid phosphatase.
Arai Y; Yoshiki T; Okada K; Yoshida O
Urol Int; 1989; 44(3):135-40. PubMed ID: 2473564
[TBL] [Abstract][Full Text] [Related]
19. Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges.
Oesterling JE; Jacobsen SJ; Chute CG; Guess HA; Girman CJ; Panser LA; Lieber MM
JAMA; 1993 Aug; 270(7):860-4. PubMed ID: 7688054
[TBL] [Abstract][Full Text] [Related]
20. Multiple marker evaluation in prostatic cancer with prostatic acid phosphatase, gamma-seminoprotein and prostate-specific antigen.
Fuse H; Umeda K; Mizuno I; Katayama T
Int Urol Nephrol; 1991; 23(5):455-63. PubMed ID: 1718922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
